Possible new Coherus Oncology shares
CHRSDilution
Known so far: no new shares from the prospectus covers read · shelf not limited by the baby-shelf rule · not yet read: warrants, converts, options, ATM.
Shelf room
- Room today not capped by the baby-shelf rule ($81.9M float, Jun 30, 2025)
How this is worked out
Shelf room on the S-3 of Nov 13, 2025: not limited by the baby-shelf rule, because the $81.9M public float stated as of Jun 30, 2025 is $75M or more. Sources: S-3 Nov 13, 2025, effective Dec 8, 2025 · public float, as of Jun 30, 2025.
What could become new Coherus Oncology (CHRS) shares, from its 10-Q, 10-K, S-3 or 424B filings.
Read so far: the cover share count (154.5M shares, +33% from 116M on Jul 31, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.
Shares outstanding
155M
Oct 2024 to Jul 2026: from 115M to 155M.
From the share count on the cover of each 10-Q and 10-K, dated as each cover states.
Follow Coherus Oncology
New shelves, offerings, 10-Qs and 10-Ks from CHRS, explained in plain English when they reach EDGAR.
Watch CHRS in the app